Pharmacokinetics Properties of Single Oral Dosing of Lu AE58054 in Subjects With Hepatic Impairment (Mild and Moderate) and in Healthy Subjects
NCT02231450
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Heptic Impairment
Interventions
DRUG:
Lu AE58054 encapsulated film-coated tablets
Sponsor
H. Lundbeck A/S